Spruce Biosciences Relocates Principal Executive Offices
Ticker: SPRB · Form: 8-K · Filed: Dec 27, 2024 · CIK: 1683553
| Field | Detail |
|---|---|
| Company | Spruce Biosciences, Inc. (SPRB) |
| Form Type | 8-K |
| Filed Date | Dec 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $343,200 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, administrative
Related Tickers: SPRU
TL;DR
SPRU just moved offices to South San Francisco, CA. No big deal yet, but keep an eye out.
AI Summary
Spruce Biosciences, Inc. announced on December 20, 2024, a change in its principal executive offices to 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080. This move from their previous address is effective immediately. The company also confirmed its fiscal year end remains December 31.
Why It Matters
A change in principal executive offices can indicate operational shifts or growth for a company. Investors should monitor if this move is associated with other significant business developments.
Risk Assessment
Risk Level: low — This filing solely reports a change of address for the company's principal executive offices, which is a routine administrative update.
Key Players & Entities
- Spruce Biosciences, Inc. (company) — Registrant
- 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080 (location) — New Principal Executive Offices
- December 20, 2024 (date) — Date of earliest event reported
- December 31 (date) — Fiscal Year End
FAQ
What is the new address for Spruce Biosciences' principal executive offices?
The new address is 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080.
When was the change of address effective?
The change was effective as of December 20, 2024.
What is Spruce Biosciences' fiscal year end?
Spruce Biosciences' fiscal year ends on December 31.
What is the company's telephone number?
The company's telephone number is (415) 655-4168.
In which state was Spruce Biosciences incorporated?
Spruce Biosciences was incorporated in Delaware.
Filing Stats: 725 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-12-27 17:15:07
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SPRB Nasdaq Global Select
- $343,200 — ontinuation at his base salary rate, or $343,200, payable in a single lump sum payment a
Filing Documents
- sprb-20241220.htm (8-K) — 48KB
- 0000950170-24-140833.txt ( ) — 172KB
- sprb-20241220.xsd (EX-101.SCH) — 31KB
- sprb-20241220_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SPRUCE BIOSCIENCES, INC. Date: December 27, 2024 By: /s/ Samir Gharib Samir Gharib President and Chief Financial Officer